Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208981 ((4R,4aR,7S,7aR,12bS)-3-methyl-2,3,4,4a,7,7a-hexahy...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 8.44 | -46.1 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM50105085 (17-cyclobutylmethyl-4,5alpha-epoxymorphinan-3,6alp...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL DrugBank KEGG PC cid PC sid UniChem Patents Similars | DrugBank US Patent | 14.3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208982 (US9233167, a-6-mPEG1-O-Morphine) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 15.7 | -44.5 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM209007 (US9233167, 6-O-mPEG4-Nalbuphine) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 17.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208983 (US9233167, a-6-mPEG2-O-Morphine) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 22.0 | -43.7 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208985 (US9233167, a-6-mPEG4-O-Morphine) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 23.1 | -43.6 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208977 (US9233167, 6-O-mPEG3-Nalbuphine) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 27.4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM50105085 (17-cyclobutylmethyl-4,5alpha-epoxymorphinan-3,6alp...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL DrugBank KEGG PC cid PC sid UniChem Patents Similars | DrugBank US Patent | 29.9 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM209008 (US9233167, 6-O-mPEG5-Nalbuphine) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 35.1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM209008 (US9233167, 6-O-mPEG5-Nalbuphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 35.6 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208986 (US9233167, a-6-mPEG5-O-Morphine) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 39.4 | -42.3 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208978 (US9233167, 6-O-mPEG6-Nalbuphine) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 44.3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208984 (US9233167, a-6-mPEG3-O-Morphine) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 50.7 | -41.6 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208988 (US9233167, a-6-mPEG7-O-Morphine) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 56.9 | -41.4 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208987 (US9233167, a-6-mPEG6-O-Morphine) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 73.0 | -40.7 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM209010 (US9233167, 6-O-mPEG7-Nalbuphine) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 77.9 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM209009 (US9233167, 6-O-mPEG8-Nalbuphine) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 79.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208989 (US9233167, a-6-mPEG9-O-Morphine) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 111 | -39.7 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM208981 ((4R,4aR,7S,7aR,12bS)-3-methyl-2,3,4,4a,7,7a-hexahy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 118 | -39.5 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208979 (US9233167, 6-O-mPEG9-Nalbuphine) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 122 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Delta-type opioid receptor (Homo sapiens (Human)) | BDBM208978 (US9233167, 6-O-mPEG6-Nalbuphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 130 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM50370595 (OXYCODONE | Oxycontin | US1184575, oxycodone | US9...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase DrugBank KEGG PC cid PC sid PDB UniChem Similars | DrugBank US Patent | 133 | -39.2 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Delta-type opioid receptor (Homo sapiens (Human)) | BDBM209008 (US9233167, 6-O-mPEG5-Nalbuphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 148 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Delta-type opioid receptor (Homo sapiens (Human)) | BDBM209007 (US9233167, 6-O-mPEG4-Nalbuphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 149 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Delta-type opioid receptor (Homo sapiens (Human)) | BDBM208979 (US9233167, 6-O-mPEG9-Nalbuphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 158 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Delta-type opioid receptor (Homo sapiens (Human)) | BDBM208977 (US9233167, 6-O-mPEG3-Nalbuphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 163 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Delta-type opioid receptor (Homo sapiens (Human)) | BDBM209009 (US9233167, 6-O-mPEG8-Nalbuphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 168 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM208979 (US9233167, 6-O-mPEG9-Nalbuphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 186 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM208977 (US9233167, 6-O-mPEG3-Nalbuphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 218 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM208978 (US9233167, 6-O-mPEG6-Nalbuphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 247 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM209009 (US9233167, 6-O-mPEG8-Nalbuphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 282 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Delta-type opioid receptor (Homo sapiens (Human)) | BDBM209010 (US9233167, 6-O-mPEG7-Nalbuphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 314 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Delta-type opioid receptor (Homo sapiens (Human)) | BDBM50105085 (17-cyclobutylmethyl-4,5alpha-epoxymorphinan-3,6alp...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL DrugBank KEGG PC cid PC sid UniChem Patents Similars | DrugBank US Patent | 319 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM209010 (US9233167, 6-O-mPEG7-Nalbuphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 346 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Specific binding is determined by subtraction of the cpm bound in the presence of 50-100× excess of cold ligand. Binding data assays were analyzed us... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM208983 (US9233167, a-6-mPEG2-O-Morphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 404 | -36.5 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM208985 (US9233167, a-6-mPEG4-O-Morphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 439 | -36.3 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM208982 (US9233167, a-6-mPEG1-O-Morphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 445 | -36.3 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM208986 (US9233167, a-6-mPEG5-O-Morphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 558 | -35.7 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM208984 (US9233167, a-6-mPEG3-O-Morphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 576 | -35.6 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208991 (US9233167, a-6-mPEG2-O-Hydroxycodone) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 632 | -35.4 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208990 (US9233167, a-6-mPEG1-O-Hydroxycodone) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 654 | -35.3 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM208988 (US9233167, a-6-mPEG7-O-Morphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 670 | -35.2 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM208987 (US9233167, a-6-mPEG6-O-Morphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 774 | -34.9 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208992 (US9233167, a-6-mPEG3-O-Hydroxycodone) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 775 | -34.9 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208993 (US9233167, a-6-mPEG4-O-Hydroxycodone) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 893 | -34.5 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM208989 (US9233167, a-6-mPEG9-O-Morphine) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.25E+3 | -33.7 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208999 (US9233167, a-6-mPEG2-O-Codeine) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.38E+3 | -33.4 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208996 (US9233167, a-6-mPEG5-O-Hydroxycodone) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.61E+3 | -33.1 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208980 (US9233167, a-6-mPEG1-O-Codeine) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.82E+3 | -32.8 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM208994 (US9233167, a-6-mPEG5-O-Hydroxycodone) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.86E+3 | -32.7 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Nektar Therapeutics US Patent | Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con... | US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 124 total ) | Next | Last >> |